Mary Madison, RN, RAC-CT, CDP
Clinical Consultant – Briggs Healthcare
Clinical Care Quick Reference for COVID-19 was updated on May 17, 2021 to include information about post-COVID conditions. Post-COVID conditions describe a range of new, returning, or ongoing health issues that persist more than four weeks after first being infected with the virus that causes COVID-19, sometimes after initial symptom recovery. This quick reference highlights key COVID-19 Clinical Care information for healthcare providers and provides selected links to full guidance and research for easier CDC web navigation.
COCA Call: Underlying Medical Conditions and Severe COVID-19: Evidence-based Information for Healthcare Providers — The Clinician Outreach and Communication Activity (COCA) will hold a call Thursday, May 27, 2021, from 2:00–3:00 p.m. (Eastern Time). During this COCA Call, presenters will update clinicians on the underlying medical conditions associated with severe COVID-19, describe the methods used to rate the evidence linking conditions to severe COVID-19, review the evidence on risk for conditions included, and provide resources for healthcare providers caring for patients with underlying medical conditions. For more information, visit COCA Calls/Webinars.
If you are unable to attend the live COCA Call, the recording will be available to view on demand on the COCA Call webpage a few hours after the live event ends.
The slide set will be available under “Call Materials” on the COCA Call webpage the day of the call.
Free Continuing Education (CE) will be offered for this COCA Call.
- Key Things to Know about COVID-19 Vaccines
- Frequently Asked Questions about Vaccination
- Vaccine Recipient Education
- Sample letter to patients to encourage COVID-19 vaccination
- Vaccines.gov (to find a vaccination provider)
- Clinical Care Considerations for COVID-19 Vaccination
- Vaccine Communication Toolkit for Medical Centers, Clinics, Pharmacies, and Clinicians
- HHS: COVID-19 Public Education Campaign Resources
- HHS: Talking Points for Health Care Leaders to Encourage Vaccine Confidence
Webinar: Georgia Tech Center for Inclusive Design and Innovation — FAQs About COVID-19 Vaccines that People with Disabilities Should Consider | May 26, 2021, 3:00 pm EST — Come hear frequently asked questions (FAQs) about COVID-19 vaccines that people with disabilities should consider. This webinar will outline the CDC guidelines, as well as explore solutions to challenges people with disabilities may experience regarding accessing COVID-19 vaccines, like making an appointment for vaccination. Participants will receive tips, resources, and guidance regarding the available vaccines as we collectively navigate this challenging time.
Registration for this webinar will close one hour before the live webinar at 2 p.m. EDT on Wednesday, May 26, 2021.
CMS updated the COVID-19 Frequently Asked Questions (FAQs) on Medicare Fee-for-Service (FFS) Billing document on May 6, 2021. The updates I found are in Section BB – Drugs & Vaccines and deal mostly with monoclonal antibodies. These Q&A begin with Question #5 on page 131 and go through Question #24 on page 145.
CMS updated the COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers document on May 24, 2021. Updates include:
- Medicare Graduate Medical Education (GME) Affiliation Agreement … page 8
- Not corrected in this document to reflect the CMS Memorandum QSO-21-17-NH is Reporting Minimum Data Set, Transfers and Discharges as well as Room Changes, etc. This remains “active” on pages 16 through 18 when in fact CMS ended those specific waivers on May 10, 2021
- Ambulance Treat in Place … page 33